145 related articles for article (PubMed ID: 29704123)
1. Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.
Zarzavadjian Le Bian A; Denet C; Tabchouri N; Donatelli G; Wind P; Louvet C; Bennamoun M; Christidis C; Perniceni T; Fuks D; Gayet B
Langenbecks Arch Surg; 2018 Jun; 403(4):443-450. PubMed ID: 29704123
[TBL] [Abstract][Full Text] [Related]
2. Colorectal cancer and its association with the metabolic syndrome: a Malaysian multi-centric case-control study.
Ulaganathan V; Kandiah M; Zalilah MS; Faizal JA; Fijeraid H; Normayah K; Gooi BH; Othman R
Asian Pac J Cancer Prev; 2012; 13(8):3873-7. PubMed ID: 23098486
[TBL] [Abstract][Full Text] [Related]
3. Abdominal obesity, glucose intolerance and decreased high-density lipoprotein cholesterol as components of the metabolic syndrome are associated with the development of colorectal cancer.
Choi YJ; Lee DH; Han KD; Shin CM; Kim N
Eur J Epidemiol; 2018 Nov; 33(11):1077-1085. PubMed ID: 30196334
[TBL] [Abstract][Full Text] [Related]
4. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
5. Association between metabolic syndrome and early-stage colorectal cancer.
Zhang C; Zhang L; Tian Y; Guan B; Li S
BMC Cancer; 2023 Oct; 23(1):1020. PubMed ID: 37872512
[TBL] [Abstract][Full Text] [Related]
6. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
7. Preoperative metabolic syndrome and prognosis after radical resection for colorectal cancer: The Fujian prospective investigation of cancer (FIESTA) study.
Peng F; Hu D; Lin X; Chen G; Liang B; Zhang H; Ji K; Huang J; Lin J; Zheng X; Niu W
Int J Cancer; 2016 Dec; 139(12):2705-2713. PubMed ID: 27560834
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.
Chen ZF; Dong XL; Huang QK; Hong WD; Wu WZ; Wu JS; Pan S
World J Surg Oncol; 2018 Aug; 16(1):163. PubMed ID: 30097069
[TBL] [Abstract][Full Text] [Related]
9. Colorectal cancer liver metastases - a population-based study on incidence, management and survival.
Engstrand J; Nilsson H; Strömberg C; Jonas E; Freedman J
BMC Cancer; 2018 Jan; 18(1):78. PubMed ID: 29334918
[TBL] [Abstract][Full Text] [Related]
10. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study.
Chung KC; Juang SE; Chen HH; Cheng KC; Wu KL; Song LC; Lee KC
BMC Gastroenterol; 2022 Nov; 22(1):453. PubMed ID: 36368935
[TBL] [Abstract][Full Text] [Related]
11. A study on relationship between metabolic syndrome and colorectal cancer.
He Q; Zhang H; Yao S; Zhu D; Lv D; Cui P; Xu Y
J BUON; 2018; 23(5):1362-1368. PubMed ID: 30570859
[TBL] [Abstract][Full Text] [Related]
12. Endoscopic and surgical treatment of malignant colorectal polyps: a population-based comparative study.
Mounzer R; Das A; Yen RD; Rastogi A; Bansal A; Hosford L; Wani S
Gastrointest Endosc; 2015 Mar; 81(3):733-740.e2. PubMed ID: 25708762
[TBL] [Abstract][Full Text] [Related]
13. The prognostic implications of primary colorectal tumor location on recurrence and overall survival in patients undergoing resection for colorectal liver metastasis.
Sasaki K; Andreatos N; Margonis GA; He J; Weiss M; Johnston F; Wolfgang C; Antoniou E; Pikoulis E; Pawlik TM
J Surg Oncol; 2016 Dec; 114(7):803-809. PubMed ID: 27792291
[TBL] [Abstract][Full Text] [Related]
14. Expressions of IGF-1, ERK, GLUT4, IRS-1 in metabolic syndrome complicated with colorectal cancer and their associations with the clinical characteristics of CRC.
Hu J; Liu X; Chi J; Che K; Feng Y; Zhao S; Wang Z; Wang Y
Cancer Biomark; 2018; 21(4):883-891. PubMed ID: 29504525
[TBL] [Abstract][Full Text] [Related]
15. The association between preoperative serum CEA concentrations and synchronous liver metastasis in colorectal cancer patients.
Pakdel A; Malekzadeh M; Naghibalhossaini F
Cancer Biomark; 2016; 16(2):245-52. PubMed ID: 26756614
[TBL] [Abstract][Full Text] [Related]
16. Metabolic syndrome is an independent risk factor for synchronous colorectal neoplasm in patients with gastric neoplasm.
Park W; Lee H; Kim EH; Yoon JY; Park JC; Shin SK; Lee SK; Lee YC; Kim WH; Noh SH
J Gastroenterol Hepatol; 2012 Sep; 27(9):1490-7. PubMed ID: 22432868
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features of gastric cancer with synchronous and metachronous colorectal cancer in Korea: are microsatellite instability and p53 overexpression useful markers for predicting colorectal cancer in gastric cancer patients?
Kim HJ; Kim N; Choi YJ; Yoon H; Shin CM; Park YS; Lee HS; Ahn SH; Park do J; Kim HH; Son IT; Kang SB; Lee DH
Gastric Cancer; 2016 Jul; 19(3):798-807. PubMed ID: 26445944
[TBL] [Abstract][Full Text] [Related]
18. The relationship of nonalcoholic fatty liver disease and metabolic syndrome for colonoscopy colorectal neoplasm.
Pan S; Hong W; Wu W; Chen Q; Zhao Q; Wu J; Jin Y
Medicine (Baltimore); 2017 Jan; 96(2):e5809. PubMed ID: 28079806
[TBL] [Abstract][Full Text] [Related]
19. Socio-economic disadvantage and demographics as factors in stage of colorectal cancer presentation and survival.
Barclay KL; Goh PJ; Jackson TJ
ANZ J Surg; 2015 Mar; 85(3):135-9. PubMed ID: 24902859
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and colorectal cancer: a cross-sectional survey.
Forootan M; Tabatabaeefar M; Yahyaei M; Maghsoodi N
Asian Pac J Cancer Prev; 2012; 13(10):4999-5002. PubMed ID: 23244098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
